IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v535y2016i7613d10.1038_nature18929.html
   My bibliography  Save this article

HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption

Author

Listed:
  • Johannes F. Scheid

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University
    Massachusetts General Hospital and Harvard Medical School)

  • Joshua A. Horwitz

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Yotam Bar-On

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Edward F. Kreider

    (Perelman School of Medicine, University of Pennsylvania)

  • Ching-Lan Lu

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Julio C. C. Lorenzi

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Anna Feldmann

    (Max Planck Institute for Informatics)

  • Malte Braunschweig

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Lilian Nogueira

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Thiago Oliveira

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Irina Shimeliovich

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Roshni Patel

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Leah Burke

    (Weill Medical College of Cornell University)

  • Yehuda Z. Cohen

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Sonya Hadrigan

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Allison Settler

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Maggi Witmer-Pack

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Anthony P. West, Jr.

    (California Institute of Technology)

  • Boris Juelg

    (Ragon Institute of MGH, MIT and Harvard)

  • Tibor Keler

    (Celldex Therapeutics, Inc.)

  • Thomas Hawthorne

    (Celldex Therapeutics, Inc.)

  • Barry Zingman

    (Montefiore Medical Center, Albert Einstein College of Medicine)

  • Roy M. Gulick

    (Weill Medical College of Cornell University)

  • Nico Pfeifer

    (Max Planck Institute for Informatics)

  • Gerald H. Learn

    (Perelman School of Medicine, University of Pennsylvania)

  • Michael S. Seaman

    (Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center)

  • Pamela J. Bjorkman

    (California Institute of Technology)

  • Florian Klein

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University
    Laboratory of Experimental Immunology, Center for Molecular Medicine Cologne (CMMC), University of Cologne
    Center of Integrated Oncology Cologne-Bonn, University Hospital Cologne)

  • Sarah J. Schlesinger

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

  • Bruce D. Walker

    (Ragon Institute of MGH, MIT and Harvard
    Howard Hughes Medical Institute, Massachusetts General Hospital)

  • Beatrice H. Hahn

    (Perelman School of Medicine, University of Pennsylvania)

  • Michel C. Nussenzweig

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University
    Howard Hughes Medical Institute, Massachusetts General Hospital)

  • Marina Caskey

    (Laboratory of Molecular Immunology, and 14 Howard Hughes Medical Institute, The Rockefeller University)

Abstract

A phase IIa clinical trial shows that the administration of the broadly neutralizing antibody 3BNC117 delays viral rebound following the discontinuation of antiretroviral therapy in patients who were chronically infected with HIV-1.

Suggested Citation

  • Johannes F. Scheid & Joshua A. Horwitz & Yotam Bar-On & Edward F. Kreider & Ching-Lan Lu & Julio C. C. Lorenzi & Anna Feldmann & Malte Braunschweig & Lilian Nogueira & Thiago Oliveira & Irina Shimelio, 2016. "HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruption," Nature, Nature, vol. 535(7613), pages 556-560, July.
    • Handle: RePEc:nat:nature:v:535:y:2016:i:7613:d:10.1038_nature18929
    DOI: 10.1038/nature18929
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature18929
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.
    File URL: https://libkey.io/10.1038/nature18929?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Miriam Rosás-Umbert & Jesper D. Gunst & Marie H. Pahus & Rikke Olesen & Mariane Schleimann & Paul W. Denton & Victor Ramos & Adam Ward & Natalie N. Kinloch & Dennis C. Copertino & Tuixent Escribà & An, 2022. "Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity," Nature Communications, Nature, vol. 13(1), pages 1-12, December.
    2. Omolara O. Baiyegunhi & Jaclyn Mann & Trevor Khaba & Thandeka Nkosi & Anele Mbatha & Funsho Ogunshola & Caroline Chasara & Nasreen Ismail & Thandekile Ngubane & Ismail Jajbhay & Johan Pansegrouw & Kri, 2022. "CD8 lymphocytes mitigate HIV-1 persistence in lymph node follicular helper T cells during hyperacute-treated infection," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    3. Christoph Kreer & Cosimo Lupo & Meryem S. Ercanoglu & Lutz Gieselmann & Natanael Spisak & Jan Grossbach & Maike Schlotz & Philipp Schommers & Henning Gruell & Leona Dold & Andreas Beyer & Armita Nourm, 2023. "Probabilities of developing HIV-1 bNAb sequence features in uninfected and chronically infected individuals," Nature Communications, Nature, vol. 14(1), pages 1-14, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:535:y:2016:i:7613:d:10.1038_nature18929. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.